University of Southern California
USC Norris Comprehensive Cancer Center
If you are a patient, please contact Keck Medical Center of USC at 800-USC-CARE.

Trial SWOG-S1609


DART: Dual Anti-CTLA-4 and Anti-PD-1 blockade in Rare Tumors

Type: Treatment
Phase: Phase II
Status: Open to Accrual
Treatments: Immunotherapy
Randomized: No
Defintions of terms and FAQ about clinical trials.
Trial Leaders/Researchers:  Heinz Josef Lenz, M.D.
Other Trial Staff:  Cheryl Kefauver, Coordinator, Lusine Raddatz, D.M., Victoria Amran, D.M., Grace Facio, Coordinator, Grace Facio, Coordinator, Jiayi Jiang, D.M., Lagrimas Ilagan, D.M., Raluca Agafitei, Coordinator, Gina Tse, Coordinator, Kristy Sartor Massopust, Coordinator, Noureddine Miloud, D.M., Shamim Jhimlee, Coordinator, Honorina Enright, D.M., Arthur Alvarez, D.M., Laurie De Oliveira, Coordinator, Amanda Luna, D.M., Charis Barg, Coordinator, Rabia Rehman, Coordinator, Bartolo Santos, Coordinator, Peter Alexander, Coordinator, Jennifer Donaldson, Coordinator, Alix Cohen, Coordinator

Staff may log in to see study documents.

Click here to see trial eligibility criteria and further details at ClinicalTrials.gov





For further information on a study, please contact the Clinical Investigation Support Office at (323) 865-0451, or clinical.trials@med.usc.edu.

To schedule a consultation with the hospital, please call our New Patient Referrals Office at (323) 865-3111.